Australia and New Zealand Lung Transplant Registry
About
The Australia and New Zealand Lung Transplant Registry (ANZLUNG) is a clinical outcome registry established in 2024. It collects and reports data on all people (adults and adolescents) in Australia and Aotearoa New Zealand who have received a lung transplant.
Funded by the Australian Organ and Tissue Authority, the Registry aims to monitor the safety, quality, and outcomes of lung transplantation, supporting clinical care, system improvement, and better outcomes for people living with advanced end-stage lung failure requiring life-saving lung transplantation.
ANZLUNG was created following the closure of the former Australian and New Zealand Cardiothoracic Transplant Registry (ANZCOTR) in 2018.
The Registry collaborates with all lung transplant units across Australia and Aotearoa New Zealand which is supported by a strong clinical network of dedicated transplant specialists. While ANZLUNG has not yet released its first formal report, its foundation provides the platform to deliver comprehensive insights into transplant activity and outcomes into the future.
ANZLUNG Governance Structure
The Australia and New Zealand Lung Transplant Registry (ANZLUNG) operates within the broader framework of the Australia and New Zealand Organ Registry and Reporting Group (ANZORRG) sharing operational resources across registries.
The ANZLUNG Clinical Steering Committee plays a central role in guiding the registry’s clinical and strategic priorities. It is composed of leading clinical experts from each lung transplant service across Australia and Aotearoa New Zealand. These representatives bring clinical expertise and frontline insights, ensuring the registry remains clinically relevant and responsive to the needs of the transplant community. In addition to clinical leads, the committee is supported by a network of clinicians and data managers embedded within each transplant service.
The Clinical Steering Committee meets regularly to provide guidance on data collection standards. There are at least four meetings each year, held on a quarterly basis. It is expected members attend a minimum of 3 meetings each calendar year. A quorum for a meeting shall comprise of 10 members.
ANZLUNG Clinical Steering Committee
Dr Phil Clayton
Technical Director
Kelly Marshall
Registry General Manager
Dr David Darley
Respiratory Medicine Specialist at St Vincent's Hospital
Dr Gregory Snell
Lung Specialist at The Alfred Hospital
A/Prof Bronwyn Levvey
Manager Service Development, Lung Transplant Service Alfred Health
Dr Sasiharan Sithamparanathan
Respiratory physician at Auckland City Hospital
Naomi Cowan
Consumer Representative ANZLUNG
Prof Peter Hopkins
Director of The Queensland Lung Transplant Service and Executive Director Heart and Lung Clinical Stream Metro North Hospital and Healthcare Service
Dr Michael Musk
Head Of Department Respiratory Medicine Fiona Stanley Hospital
Natalia Belousova
Respiratory and Sleep Medicine Physician at Riverina Respiratory and Sleep Centre
Latest Reports
Partners
ANZLUNG is supported by a network of contributors and partners. These include:
- Alfred Hospital
- Auckland City Hospital
- Fiona Stanley Hospital
- St Vincent’s Hospital
- The Prince Charles Hospital
- Australian Government Organ and Tissue Authority (AOTA)
- South Australian Health and Medical Research Institute (SAHMRI)
The Transplantation Society of Australia and New Zealand (TSANZ)
